ArticleNature communications2018

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Yong Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.